Found: 1
Select item for more details and to access through your institution.
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 556, doi. 10.1007/s10637-017-0470-z
- By:
- Publication type:
- Article